Grace Larry
Director/Board Member at Generate Biomedicines, Inc.
Grace Larry active positions
| Companies | Position | Start | End |
|---|---|---|---|
Alix Ventures
 Alix Ventures Investment ManagersFinance Alix Ventures is an venture capital firm founded in 2019 by Chas Pulido. The firm is headquartered in San Francisco, California. | Private Equity Investor | - | - |
Generate Biomedicines, Inc.
 Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | Director/Board Member | 30/06/2021 | - |
Career history of Grace Larry
Former positions of Grace Larry
| Companies | Position | Start | End |
|---|---|---|---|
| AMGEN INC. | Director/Board Member | 30/04/2019 | 31/03/2021 |
| NOVARTIS AG | Corporate Officer/Principal | 31/12/2010 | 31/03/2013 |
Training of Grace Larry
| Northwestern University School of Law | Graduate Degree |
| Kellogg School of Management | Masters Business Admin |
| University of California, Berkeley | Graduate Degree |
Statistics
International
| United States | 7 |
| Switzerland | 2 |
Operational
| Director/Board Member | 2 |
| Graduate Degree | 2 |
| Private Equity Investor | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 4 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| Private companies | 2 |
|---|---|
Alix Ventures
Alix Ventures Investment ManagersFinance Alix Ventures is an venture capital firm founded in 2019 by Chas Pulido. The firm is headquartered in San Francisco, California. | Finance |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | Health Technology |
- Stock Market
- Insiders
- Grace Larry
- Experience